Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extendedspectrum- beta-lactamase-producing Enterobacteriaceae

Creative Commons License

Raquel Palacios-Baena Z., Gutierrez-Gutierrez B., De Cueto M., Viale P., Venditti M., Hernandez-Torres A., ...More

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol.72, no.3, pp.906-913, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 72 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.1093/jac/dkw513
  • Journal Name: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.906-913
  • Hacettepe University Affiliated: Yes

Abstract

Background. Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a predictive risk score for 30 day mortality.